192 related articles for article (PubMed ID: 16497621)
1. Intestinal permeability in cirrhotic patients with and without ascites.
Kalaitzakis E; Johansson JE; Bjarnason I; Björnsson E
Scand J Gastroenterol; 2006 Mar; 41(3):326-30. PubMed ID: 16497621
[TBL] [Abstract][Full Text] [Related]
2. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?
Scarpellini E; Valenza V; Gabrielli M; Lauritano EC; Perotti G; Merra G; Dal Lago A; Ojetti V; Ainora ME; Santoro M; Ghirlanda G; Gasbarrini A
Am J Gastroenterol; 2010 Feb; 105(2):323-7. PubMed ID: 19844200
[TBL] [Abstract][Full Text] [Related]
3. Intestinal permeability is increased in patients with advanced cirrhosis.
Pascual S; Such J; Esteban A; Zapater P; Casellas JA; Aparicio JR; Girona E; Gutiérrez A; Carnices F; Palazón JM; Sola-Vera J; Pérez-Mateo M
Hepatogastroenterology; 2003; 50(53):1482-6. PubMed ID: 14571769
[TBL] [Abstract][Full Text] [Related]
4. [Relationships between ascitic bacterial DNA and plasma endotoxin, gut flora and intestinal permeability in cirrhotic patients].
Jiang CY; Wang BE; Wang JC
Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):594-8. PubMed ID: 18752746
[TBL] [Abstract][Full Text] [Related]
5. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.
Jenkins RT; Jones DB; Goodacre RL; Collins SM; Coates G; Hunt RH; Bienenstock J
Am J Gastroenterol; 1987 Nov; 82(11):1159-64. PubMed ID: 3118697
[TBL] [Abstract][Full Text] [Related]
6. Is an increased intestinal permeability a valid predictor of relapse in Crohn disease?
Jørgensen J; Ranløv PJ; Bjerrum PJ; Diemer H; Bisgaard K; Elsborg L
Scand J Gastroenterol; 2001 May; 36(5):521-7. PubMed ID: 11346207
[TBL] [Abstract][Full Text] [Related]
7. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
8. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
9. Increased intestinal permeability in malnourished patients with liver cirrhosis.
Norman K; Pirlich M; Schulzke JD; Smoliner C; Lochs H; Valentini L; Bühner S
Eur J Clin Nutr; 2012 Oct; 66(10):1116-9. PubMed ID: 22872031
[TBL] [Abstract][Full Text] [Related]
10. Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis.
Kalaitzakis E; Simrén M; Abrahamsson H; Björnsson E
Scand J Gastroenterol; 2007 Feb; 42(2):237-46. PubMed ID: 17327944
[TBL] [Abstract][Full Text] [Related]
11. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites.
Pérez-Paramo M; Muñoz J; Albillos A; Freile I; Portero F; Santos M; Ortiz-Berrocal J
Hepatology; 2000 Jan; 31(1):43-8. PubMed ID: 10613726
[TBL] [Abstract][Full Text] [Related]
12. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes.
Zuckerman MJ; Menzies IS; Ho H; Gregory GG; Casner NA; Crane RS; Hernandez JA
Dig Dis Sci; 2004 Apr; 49(4):621-6. PubMed ID: 15185867
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis.
Jepsen P; Vilstrup H; Møller JK; Sørensen HT
Hepatogastroenterology; 2003; 50(54):2133-6. PubMed ID: 14696480
[TBL] [Abstract][Full Text] [Related]
14. [Increased intestinal permeability to 51 Cr-EDTA among children with persistent diarrhea].
Sawamura R; Fernandes MI; Troncon LE; Iazigi N
Arq Gastroenterol; 1997; 34(1):55-61. PubMed ID: 9458961
[TBL] [Abstract][Full Text] [Related]
15. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.
Bauer TM; Steinbrückner B; Brinkmann FE; Ditzen AK; Schwacha H; Aponte JJ; Pelz K; Kist M; Blum HE
Am J Gastroenterol; 2001 Oct; 96(10):2962-7. PubMed ID: 11693333
[TBL] [Abstract][Full Text] [Related]
16. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.
Assimakopoulos SF; Tsamandas AC; Tsiaoussis GI; Karatza E; Triantos C; Vagianos CE; Spiliopoulou I; Kaltezioti V; Charonis A; Nikolopoulou VN; Scopa CD; Thomopoulos KC
Eur J Clin Invest; 2012 Apr; 42(4):439-46. PubMed ID: 22023490
[TBL] [Abstract][Full Text] [Related]
17. Association between model for end-stage liver disease and spontaneous bacterial peritonitis.
Obstein KL; Campbell MS; Reddy KR; Yang YX
Am J Gastroenterol; 2007 Dec; 102(12):2732-6. PubMed ID: 17714556
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
[TBL] [Abstract][Full Text] [Related]
19. Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study.
Thalheimer U; De Iorio F; Capra F; del Mar Lleo M; Zuliani V; Ghidini V; Tafi MC; Caburlotto G; Gennari M; Burroughs AK; Vantini I
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1228-34. PubMed ID: 20512041
[TBL] [Abstract][Full Text] [Related]
20. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.
Pande C; Kumar A; Sarin SK
Aliment Pharmacol Ther; 2009 Jun; 29(12):1273-81. PubMed ID: 19302262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
